Who Paid My Doc
Carlos Salgado Rodriguez
Interventional Cardiology Arecibo, PR Medical Doctor
NPI 1831297217 CMS profile 355199
702 Ave San Luis, Arecibo, PR 00612
General payments
$2,676
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Carlos Salgado Rodriguez of Arecibo, PR is reported in the CMS Open Payments database as having received $2,676 across 97 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 24th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $390 | 8 | |
| 2022 | General | $664 | 20 | |
| 2021 | General | $597 | 24 | |
| 2020 | General | $411 | 21 | |
| 2019 | General | $614 | 24 |
Beside peers
- Carlos Salgado Rodriguez
- Interventional Cardiology median
- Middle half of Interventional Cardiology
- National median
In program year 2025, general payments to Carlos Salgado Rodriguez were reported at $0. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.
Show as a table
| Year | Carlos Salgado Rodriguez | Interventional Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $614 | $1,097 | $329–$3,048 | $163 |
| 2020 | $411 | $473 | $161–$1,480 | $114 |
| 2021 | $597 | $677 | $233–$1,827 | $132 |
| 2022 | $664 | $978 | $333–$2,724 | $149 |
| 2023 | $390 | $1,136 | $382–$2,986 | $160 |
| 2024 | $0 | $1,181 | $395–$3,326 | $164 |
| 2025 | $0 | $1,092 | $366–$3,019 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 6 billing codesPaid by Medicare
$5,078
Medicare patients
22
Services billed
34
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 64% | |
| Atrial fibrillation | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
97 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Cardiology in Puerto Rico
Damian Grovas Abad
Interventional Cardiology · San Juan, PR
Eric Carro Jimenez
Interventional Cardiology · San Juan, PR
Hector Martinez Gonzalez
Interventional Cardiology · Mayaguez, PR
Alejandro Lopez Mas
Interventional Cardiology · Ponce, PR
Ricardo Santiago
Interventional Cardiology · Manati, PR
Edwin I Perez Marrero
Interventional Cardiology · San Juan, PR
Related records
Interventional Cardiology in Puerto Rico
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Puerto Rico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.